Looking for a research and development job? Check out the BioSpace list of 12 companies hiring life sciences professionals like you.

Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup ...

The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Vitamin C has long been considered a powerhouse nutrient that can support your immune system. But this popular vitamin also plays a role in wound healing and the ability to absorb iron, making it a ...

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced ...

HiBird makes its debut at this year's McLane Engage trade show. HiBird products boast a long shelf life and the flexibility to be prepared in either a fryer or rapid cook oven and can be adapted to ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)-- Rallybio ...